Table 2.
Factors longitudinally associated with pain medication denial among people who use drugs in Vancouver, Canada
| Unadjusted (n = 4179) | Adjusted (n = 4134**) | |||
|---|---|---|---|---|
| Characteristic | Odds Ratio (95% CI) | p – value | Odds Ratio (95% CI) | p – value |
| Age | ||||
| Per year older | 0.97 (0.96–0.98) | < 0.001 | 0.98 (0.97–0.99)) | < 0.001 |
| Sex | ||||
| Male vs. female | 1.06 (0.85–1.30) | 0.616 | ||
| Ethnicity/Ancestry | ||||
| Indigenous vs. White | 0.92 (0.75–1.13) | 0.439 | ||
| POC/other vs. White | 0.71 (0.41–1.25) | 0.237 | ||
| Education completed | ||||
|
≥ High school vs < High school |
1.08 (0.88–1.33) | 0.442 | ||
| Living with HIV | ||||
| Yes vs. no | 0.64 (0.53–0.79) | < 0.001 | 0.83 (0.67–1.03) | 0.088 |
| HCV status | ||||
| Seropositive vs. seronegative | 0.86 (0.67–1.10) | 0.223 | ||
| Physical disability | ||||
| Yes vs. no | 1.07 (0.89–1.28) | 0.474 | ||
| Housing status* | ||||
| Unstable vs. stable | 1.26 (1.06–1.49) | 0.008 | 1.11 (0.92–1.33) | 0.274 |
| Downtown Eastside residency* | ||||
| Yes vs. no | 1.12 (0.94–1.35) | 0.208 | ||
| Incarceration* | ||||
| Yes vs. no | 2.00 (1.44–2.76) | < 0.001 | 1.39 (0.98–1.96) | 0.066 |
| Opioid agonist therapy* | ||||
| Yes vs. no | 1.38 (1.15–1.66) | 0.001 | 1.32 (1.09–1.61) | 0.005 |
| Non-fatal overdose* | ||||
| Yes vs. no | 1.86 (1.52–2.28) | < 0.001 | 1.51 (1.22–1.88) | < 0.001 |
| Self-manage pain* | ||||
| Yes vs. no | 2.74 (2.30–3.26) | < 0.001 | 2.48 (2.04–3.00) | < 0.001 |
| Heavy alcohol use* | ||||
| Yes vs. no | 1.15 (0.93–1.43) | 0.191 | ||
| Daily cannabis use* | ||||
| Yes vs. no | 1.16 (0.97–1.40) | 0.11 | ||
| Daily stimulant use*,† | ||||
| Yes vs. no | 1.39 (1.16–1.66) | < 0.001 | 1.12 (0.92–1.36) | 0.251 |
| Daily heroin/unregulated opioid use* | ||||
| Yes vs. no | 1.91 (1.55–2.35) | < 0.001 | 1.32 (1.05–1.66) | 0.018 |
| Any injection drug use* | ||||
| Yes vs. no | 1.61 (1.36–1.92) | < 0.001 | 1.12 (0.91–1.38) | 0.302 |
| Daily non-medical prescription opioid use* | ||||
| Yes vs. no | 1.36 (1.02–1.82) | 0.034 | 1.24 (0.91–1.69) | 0.177 |
| Period | ||||
| 2016–2020 vs. 2012–2015 | 1.05 (0.90–1.23) | 0.509 | ||
GEE generalized estimating equations, CI confidence interval, POC person of colour, HIV human immunodeficiency virus, HCV hepatitis C virus
*in the six months prior to the interview date
†Defined as daily cocaine, crack, or meth use
**45 observations were removed from the final model due to missing data